Bringing Buprenorphine – Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience
Leslie Amass, Ph.D., Walter Ling, M.D., Thomas E. Freese, Ph.D., Chris Reiber, Ph.D., M.P.H., Jeffrey J. Annon, M.A., Allan J. Cohen, M.A., M.F.T., Dennis McCarty, Ph.D., Malcolm S. Reid, Ph.D., Lawrence S. Brown, Jr., M.D., Cynthia Clark, M.S.N., C.R.N.P., Douglas M. Ziedonis, M.D., Jonathan Krejci, Ph.D., Susan Stine, M.D., Ph.D., Theresa Winhusen, Ph.D., Greg Brigham, Ph.D., Dean Babcock, M.S.W., L.C.S.W., Joan A. Muir, Ph.D., Betty J. Buchan, Ph.D., and Terry Horton, M.D.
Am J Addict. 2004; 13(Suppl 1): S42–S66 *PDF [247 kB]